scholarly journals The effect of Spinal Cord Stimulation on Chronic Pain in Buerger’s Disease: Case Report and Brief Literature Review

2013 ◽  
Vol 65 (2) ◽  
pp. 167 ◽  
Author(s):  
Sang-Wook Ryu ◽  
Hee-Jung Jeon ◽  
Sam-Soon Cho ◽  
Rak-Min Choi ◽  
Jin-Sun Yoon ◽  
...  

2019 ◽  
pp. 41-48
Author(s):  
Olga Santos

Buerger’s disease (BD) or thromboangeitis obliterants is a nonatherosclerotic segmental inflammation of the medium- and small-size arteries and vessels of the extremities. The pathogenesis of this process remains unclear. This disease is typically seen in male smokers under 45 years of age, and successful therapy is possible only with abstinence from tobacco. Methods to control ischemic pain include nonpharmacological and pharmacological options, such as prostanoids, or surgical intervention (sympathectomy or revascularization). This case report describes an unusual case of Buerger’s disease in a 60-year-old woman with a moderate smoking habit. Despite apparent tobacco abstinence and therapeutic optimization, there was no clinical improvement in this patient with pharmacological treatment. Attending to the imminent risk of amputation of her fingers, spinal cord stimulation (SCS) system implantation was the chosen therapeutic option. Transcutaneous oxygen pressure (TcPO2) was measured at different points in time after implantation and there was a significant increment of TcPO2 in both hands. In fact, the patient reported no pain after the first month of spinal stimulation; analgesics were progressively reduced and complete healing of ulcers was achieved. Furthermore, the patient reported a substantial improvement in her quality of life and total functional recovery in her hands mobilization after 6 months of treatment. The Brief Pain Inventory Scale and EuroQol- 5D scale were used to evaluate disease progression and its impact on quality of life. SCS system implantation is considered a safe procedure and cost-effective in the long term. The mechanisms behind these effects are still unknown, but SCS is a promising treatment option. More studies that include larger numbers of patients are needed. Key words: Buerger, tobacco, ischemia, amputation, electrical spinal cord stimulation, transcutaneous oxygen pressure


Neurosurgery ◽  
1991 ◽  
Vol 28 (1) ◽  
pp. 65-71 ◽  
Author(s):  
Roberto Spiegelmann ◽  
William A. Friedman

Abstract Forty-three patients with chronic pain disorders of different causes were selected for spinal cord stimulation. All underwent implantation of a ribbon electrode through a small laminotomy, under general anesthesia. Thirteen patients (30%) failed to obtain significant pain relief during a period of trial stimulation, and their electrodes were removed. The remainder underwent a definitive implant and were followed for a mean of 13 months (range, 3-33 months). Nineteen of them (63%) continued to experience pain relief. A detailed analysis of this series, as well as a literature review, is presented.


1995 ◽  
pp. 207-213
Author(s):  
K. Ktenidis ◽  
L. Claeys ◽  
C. Bartels ◽  
S. Horsch

Angiology ◽  
2002 ◽  
Vol 53 (3) ◽  
pp. 341-347 ◽  
Author(s):  
F. Chierichetti ◽  
S. Mambrini ◽  
A. Bagliani ◽  
A. Odero

2004 ◽  
Vol 100 (3) ◽  
pp. 254-267 ◽  
Author(s):  
Tracy Cameron

Object. The purpose of this report was to examine the available literature to determine the safety and efficacy of spinal cord stimulation (SCS) for the treatment of chronic pain of the trunk and limbs. Methods. The author identified 68 studies that fulfilled the efficacy inclusion/exclusion criteria, grouped on the basis of pain indication, with an overall population of 3679 patients. Fifty-one studies fulfilled all safety inclusion/exclusion criteria. Based on the literature review, the author found that SCS had a positive, symptomatic, long-term effect in cases of refractory angina pain, severe ischemic limb pain secondary to peripheral vascular disease, peripheral neuropathic pain, and chronic low-back pain, and that, in general, SCS was a safe and effective treatment for a variety of chronic neuropathic conditions. Conclusions. Despite the positive findings, there is an urgent need for randomized, controlled, long-term studies on the efficacy of SCS involving larger patient sample sizes.


2005 ◽  
Vol 41 (5) ◽  
pp. 830-836 ◽  
Author(s):  
Konstantinos P. Donas ◽  
Stefan Schulte ◽  
Kiriakos Ktenidis ◽  
Svante Horsch

Gut and Liver ◽  
2010 ◽  
Vol 4 (2) ◽  
pp. 287-291 ◽  
Author(s):  
Kyeong Soo Lee ◽  
Chang Nyol Paik ◽  
Woo Chul Chung ◽  
Kang Moon Lee ◽  
Sung Hoon Jung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document